Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy
Author(s) -
Dingding Xiong,
Toshitaka Yajima,
Byung-Kwan Lim,
Antine E. Stenbit,
Andrew Dublin,
Nancy D. Dalton,
Daphne Summers-Torres,
Jeffery D. Molkentin,
Hervé Duplain,
Rainer Wessely,
Ju Chen,
Kirk U. Knowlton
Publication year - 2006
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.631093
Subject(s) - tamoxifen , medicine , cardiomyopathy , myocyte , dystrophin , endocrinology , protease , cardiac fibrosis , heart failure , biology , duchenne muscular dystrophy , enzyme , biochemistry , cancer , breast cancer
Enterovirus infection is a cause of cardiomyopathy. We previously demonstrated that enteroviral protease 2A directly cleaves the cytoskeletal protein dystrophin. However, the direct effect of protease 2A in enteroviral cardiomyopathy is less clear because other viral proteins are also expressed with viral infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom